Robert Woolson to Treatment Outcome
This is a "connection" page, showing publications Robert Woolson has written about Treatment Outcome.
Connection Strength
0.343
-
To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials. BMJ Open. 2016 12 30; 6(12):e013096.
Score: 0.059
-
Slope estimation for informatively right censored longitudinal data modelling the number of observations using geometric and Poisson distributions: application to renal transplant cohort. Stat Methods Med Res. 2015 Dec; 24(6):819-35.
Score: 0.042
-
Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence. Hypertension. 2010 Jun; 55(6):1289-95.
Score: 0.037
-
Outcomes of total alloplastic replacement with periarticular autogenous fat grafting for management of reankylosis of the temporomandibular joint. J Oral Maxillofac Surg. 2008 Sep; 66(9):1794-803.
Score: 0.033
-
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse. 2006; 32(4):577-87.
Score: 0.028
-
Applying a phase II futility study design to therapeutic stroke trials. Stroke. 2005 Nov; 36(11):2410-4.
Score: 0.027
-
Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence. J Clin Psychopharmacol. 2005 Aug; 25(4):349-57.
Score: 0.027
-
Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Stroke. 1994 Sep; 25(9):1746-51.
Score: 0.013
-
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke. 2014 May; 45(5):1408-14.
Score: 0.012
-
Analyses of renal outcome following transplantation adjusting for informative right censoring and demographic factors: A longitudinal study. Ren Fail. 2010 Jul; 32(6):691-8.
Score: 0.009
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.008
-
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level. Arch Intern Med. 2007 Mar 12; 167(5):502-6.
Score: 0.008
-
Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem. Biometrics. 2005 Jun; 61(2):532-9.
Score: 0.007
-
A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
Score: 0.007
-
Effect of prior aspirin use on stroke severity in the trial of Org 10172 in acute stroke treatment (TOAST). Stroke. 2001 Dec 01; 32(12):2836-40.
Score: 0.005
-
Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13; 53(1):122-5.
Score: 0.004
-
Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999 Jul 13; 53(1):126-31.
Score: 0.004
-
Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999 Jan 15; 52(2):280-4.
Score: 0.004
-
Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Control Clin Trials. 1997 Aug; 18(4):358-77.
Score: 0.004
-
Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis. 1992; 22(2):99-103.
Score: 0.003